Medical Library | Shanghai Cardiovascular and Emergency Medicine Series
Tongji University-affiliated Shanghai Oriental Hospital is developing a distinctive clinical innovation profile in advanced heart failure, atrial fibrillation, structural heart disease, stroke emergency care, sepsis, and acute respiratory distress syndrome. Its programs combine medical engineering, mechanical circulatory support, regenerative medicine, emergency systems, randomized clinical evidence, and rapid pathogen diagnosis.
This Medical Library review summarizes two representative teams and directions based on the information provided. It also explains how CMCS can help international patients and families prepare for specialist and emergency-care consultations in Shanghai.
1. Cardiovascular Medicine and the Heart Center: Artificial Heart Engineering for Advanced Heart Failure
Leads: Professors He Ben, Han Wei, and Academician-level cardiovascular specialist Chen Yihan
Focus: Heart failure, atrial fibrillation, structural heart disease, artificial-heart systems, stem-cell research, and neuromodulation.
Advanced heart failure can progress despite medication, catheter procedures, and conventional surgery. Mechanical circulatory support may be considered when the heart cannot pump enough blood to support the body, while regenerative and neuromodulatory approaches are being studied as additional strategies.
Key 2025–2026 progress
- East Heart: The artificial-heart system entered the product-production stage and received the top prize in a national clinical innovation and invention competition.
- Heart-failure research: The program continues to explore stem-cell treatment and nerve-block approaches for heart failure.
Moving an artificial-heart system into production is an important engineering and translational step, but it does not mean that the device is automatically available or appropriate for every patient. Families should confirm the device's indication, support duration, implantation pathway, anticoagulation requirements, infection risks, battery or external-control system, and whether the program is part of a clinical study.
Stem-cell therapy and nerve-block interventions remain dependent on the quality of clinical evidence. Patients should ask whether the treatment is approved, whether it is being tested in a randomized trial, how heart function is measured, and what happens if the therapy does not provide sufficient support.
For broader cardiovascular background, see our Heart Valve Disease Treatment in Shanghai Medical Library guide.
Clinical profile: A medical-engineering program combining artificial-heart production, regenerative research, and neuromodulation for advanced heart failure.
2. Emergency Medicine: Ultra-Early Stroke Treatment and Rapid Sepsis Diagnosis
Lead: Professor Li Gang, Vice President of the hospital
Focus: Prehospital stroke emergency care, sepsis and bloodstream infection, and acute respiratory distress syndrome.
Key 2025–2026 progress
- Ultra-early stroke treatment: The program received the First Prize of the 2026 Shanghai Science and Technology Award for its work on ultra-early stroke care. It led what was described as the world's largest randomized controlled trial supporting an intensive early blood-pressure-lowering strategy for intracerebral hemorrhage, with a reported 25% reduction in disability and death risk.
- Bloodstream infection diagnosis: The reported confirmation time for the pathogen causing sepsis was reduced from approximately 72 hours to four hours.
Stroke treatment is highly time-sensitive. For intracerebral hemorrhage, early blood-pressure management must be balanced against the risk of reducing blood flow to vulnerable brain tissue. The appropriate target depends on the bleeding location and volume, neurological status, previous blood pressure, kidney function, large-vessel disease, and the treatment protocol used by the emergency team.
Rapid identification of bloodstream infection can help clinicians choose antibiotics more precisely and reduce delays in treating sepsis. It must still be interpreted with blood cultures, imaging, examination, immune status, and local resistance patterns. A faster test does not eliminate the need for clinical judgment.
Our Sepsis and Multi-Organ Failure article provides related critical-care background. Patients and families can also read our Stroke guide for international patients in Shanghai.
Clinical profile: An emergency-care program built around earlier stroke intervention, faster pathogen identification, and intensive-care coordination.
3. Why Ultra-Early Emergency Care Matters
Emergency medicine is not only about a single procedure. It is a chain that begins with symptom recognition and transport, continues through triage and imaging, and extends to intensive care, rehabilitation, and secondary prevention.
For suspected stroke, families should note the time the patient was last known well, avoid giving food or medication without medical advice, and seek emergency help immediately. For suspected sepsis, fever, confusion, low blood pressure, rapid breathing, reduced urine output, or sudden deterioration require urgent evaluation.
For severe heart failure or cardiogenic shock, the receiving team may need to evaluate oxygenation, blood pressure, kidney function, rhythm, coronary disease, valve disease, and whether mechanical circulatory support is necessary. The speed and quality of transfer can influence the available treatment options.
Our Lung Disease and Critical Care in Shanghai Medical Library article provides additional context on respiratory failure and critical-care support.
4. How CMCS Helps International Patients and Families Communicate with Specialists
For an international patient seeking heart-failure, cardiac-device, stroke, sepsis, or critical-care consultation in Shanghai, the first step is to match the clinical question with the right specialist team. China Medical Concierge Shanghai (CMCS) is a health management and medical coordination service that helps patients connect with specialist doctors and hospital resources in Shanghai. CMCS is not a hospital and does not independently diagnose or prescribe treatment.
For a planned cardiovascular consultation, CMCS can help organize echocardiography, cardiac MRI or CT, coronary angiography, ECG and rhythm records, kidney function, medication history, previous admissions, and current symptoms. For emergency or post-emergency review, the case summary may include ambulance and emergency records, brain imaging, blood-pressure readings, cultures, antibiotic history, ventilator support, and ICU progress notes.
CMCS can help families prepare focused questions such as:
- Is an artificial heart or mechanical circulatory support device appropriate for this patient's stage of heart failure?
- Is the proposed device or treatment approved, part of a clinical trial, or still in product development?
- What are the risks of implantation, anticoagulation, infection, bleeding, stroke, and device malfunction?
- For intracerebral hemorrhage, what blood-pressure target and monitoring plan are being used?
- For sepsis, how will the rapid pathogen result change antibiotic selection and duration?
- What additional cardiac, neurological, respiratory, kidney, or rehabilitation support will be required?
- What alternatives exist if the patient is not eligible for the proposed treatment?
During the consultation, CMCS can assist with appointment coordination, medical interpretation, communication between the patient or family and the care team, and clarification of the doctor's recommendations. Afterward, a case manager can help organize the proposed next steps, identify additional tests or records, clarify the follow-up schedule, and coordinate further communication with the hospital.
In an emergency, CMCS does not replace the local emergency service or delay urgent treatment. The final treatment decision must be made by the patient, family where appropriate, and the treating medical team. CMCS does not independently select a device, drug, operation, or clinical trial.
To learn more about specialist consultations and treatment coordination in Shanghai, contact CMCS:
Email: contract@medicalsh.com
WhatsApp: Contact CMCS on WhatsApp
Website: medicalsh.com
Conclusion
The Shanghai Oriental Hospital programs reviewed here show how cardiovascular and emergency medicine are advancing through artificial-heart engineering, regenerative and neuromodulatory research, ultra-early stroke treatment, and rapid sepsis diagnosis.
For patients and families, the most important goal is to reach the right specialist team quickly and understand the evidence, risks, alternatives, and follow-up requirements. This article was prepared from the team and program information provided for editorial use. Research findings, device status, clinical claims, and treatment access should be confirmed through the hospital, research team, regulatory authorities, and formally published studies. This article is for medical education only and is not individualized medical advice.
0 commentaire